ISS [iSoftStone] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS Page 3 4 2]
[Form 6-K TABLE OF CONTENTS Page 3 4 2]
[Form 6-K TABLE OF CONTENTS Page 3 4 2]
[Description 99.1 Announcement on 2011/04/26: Represent subsidiary EverRich Energy Corporation and JenEnergy System Corp. to announce related materials on merger 99.2 Announcement on 2011/04/26: UMC will convene 1Q 2011 investor conference 99.3 Announcement on 2011/04/27: UMC announced its unconsolidated operating results for the first quarter of 2011 99.4 Announcement on 2011/04/27: UMC announces board resolution to amend partial acquisition offer] [FORM 6-K May 26, 2011 United Microelectronics Corporation No. 3 Li Hsin Road II x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu Chief Financial Officer Description 99 6K on 20110601 6-K 1 htm_5857.htm LIVE FILING]
[Description 99.1 Announcement on 2011/04/26: Represent subsidiary EverRich Energy Corporation and JenEnergy System Corp. to announce related materials on merger 99.2 Announcement on 2011/04/26: UMC will convene 1Q 2011 investor conference 99.3 Announcement on 2011/04/27: UMC announced its unconsolidated operating results for the first quarter of 2011 99.4 Announcement on 2011/04/27: UMC announces board resolution to amend partial acquisition offer] [FORM 6-K May 26, 2011 United Microelectronics Corporation No. 3 Li Hsin Road II x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu Chief Financial Officer Description 99 6K on 20110601 6-K 1 htm_5857.htm LIVE FILING]
[FORM OF RESTRICTED SHARE AWARDREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Participant: _______ Number of Restricted Shares granted:_______ ***** 2. Grant of Restricted Share Award . Vesting 3.1 _______________________________________ 3.3 If the Participants employment with thempany and/or its Subsidiaries terminates due to the Participant's death, Disability or Retirement, the Participant shall become 100% vested] [FORM OF NON-QUALIFIED STOCK OPTIONREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Optionee:________ Per Share Exercise Price: $________ Number of Option Shares subject to this Option: ________ ***** 2. Grant of Option . 3. No Dividends Equivalents . 4. Exercise of this Option . 4.1 4.2 4.3] [EMPLOYMENTREEMENT WITNESSETH: WHEREAS, thempany is engaged in the business of develop, manufacture, and marketecialty pharmaceutical products in China (the business); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable him to be thempanys Chief Financial Officer; and WHEREAS, based on such representation, and thempanys reasonable due diligence, thempany]
[Contact: WSP Holdings Limited CCG Investor Relations, Inc. Ms. Judy Zhu, IR Director Ms. Elaine Ketchmere, Partner Phone: +86-510-8536-0401 Phone: +1-310-954-1345 (Los Angeles) E-mail: info@wsphl.com E-mail: elaine.ketchmere@ccgir.com http://www.wsphl.com http://www.ccgirasia.com Mr. Crocker Coulson, President Phone: +1-646-213-1915 (New York) Email: crocker.coulson@ccgir.com WSP Holdings Appoints New Independent Director Wuxi, China, June 1 , 2011 Since 2001 Mr. Michael Muhan Liu has been] [WSP HOLDINGS LIMITED By : Name : Longhua Piao Title : Chairman and Chief Executive Officer 2 Description______________________________________________ 99.1 Press release]
[FORM OF RESTRICTED SHARE AWARDREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Participant: _______ Number of Restricted Shares granted:_______ ***** 2. Grant of Restricted Share Award . Vesting 3.1 _______________________________________ 3.3 If the Participants employment with thempany and/or its Subsidiaries terminates due to the Participant's death, Disability or Retirement, the Participant shall become 100% vested] [FORM OF NON-QUALIFIED STOCK OPTIONREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Optionee:________ Per Share Exercise Price: $________ Number of Option Shares subject to this Option: ________ ***** 2. Grant of Option . 3. No Dividends Equivalents . 4. Exercise of this Option . 4.1 4.2 4.3] [EMPLOYMENTREEMENT WITNESSETH: WHEREAS, thempany is engaged in the business of develop, manufacture, and marketecialty pharmaceutical products in China (the business); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable him to be thempanys Chief Financial Officer; and WHEREAS, based on such representation, and thempanys reasonable due diligence, thempany]
[Contact: WSP Holdings Limited CCG Investor Relations, Inc. Ms. Judy Zhu, IR Director Ms. Elaine Ketchmere, Partner Phone: +86-510-8536-0401 Phone: +1-310-954-1345 (Los Angeles) E-mail: info@wsphl.com E-mail: elaine.ketchmere@ccgir.com http://www.wsphl.com http://www.ccgirasia.com Mr. Crocker Coulson, President Phone: +1-646-213-1915 (New York) Email: crocker.coulson@ccgir.com WSP Holdings Appoints New Independent Director Wuxi, China, June 1 , 2011 Since 2001 Mr. Michael Muhan Liu has been] [WSP HOLDINGS LIMITED By : Name : Longhua Piao Title : Chairman and Chief Executive Officer 2 Description______________________________________________ 99.1 Press release]
[Lentuo International Inc. Announces First Quarter 2011 Financial Results · 1Q11 Revenue s Increased 2.9% Year-Over-Year to $91.3 Million · 1Q11 Net Income Increased 4.2% Year-Over-Year to $4.6 Million · 1Q11 Gross Profit Increased 1 9 . 8 % Year-Over-Year to $12.0 Million BEIJING May 31 , 2011 Lentuo International Inc. (NYSE: LAS) (Lentuo or the Company), the] [FORM 6-K LENTUO INTERNATIONAL INC. A-18 Huagong Road, Guangqumenwai Chaoyang District, Beijing 100022 Peoples Republic of China (86-10) 6778 3955 (Address of Principal Executive Offices) reports under cover of Form 20-F or Form 40-F.) Form 20-F x Form 40-F o Yes o No x Yes o No x Yes o No x S]
[Lentuo International Inc. Announces First Quarter 2011 Financial Results · 1Q11 Revenue s Increased 2.9% Year-Over-Year to $91.3 Million · 1Q11 Net Income Increased 4.2% Year-Over-Year to $4.6 Million · 1Q11 Gross Profit Increased 1 9 . 8 % Year-Over-Year to $12.0 Million BEIJING May 31 , 2011 Lentuo International Inc. (NYSE: LAS) (Lentuo or the Company), the] [FORM 6-K LENTUO INTERNATIONAL INC. A-18 Huagong Road, Guangqumenwai Chaoyang District, Beijing 100022 Peoples Republic of China (86-10) 6778 3955 (Address of Principal Executive Offices) reports under cover of Form 20-F or Form 40-F.) Form 20-F x Form 40-F o Yes o No x Yes o No x Yes o No x S]